Getting Biased Treatment Study: How Psychotherapy and Antidepressants Change Brain Activity in Chronic Depression (GETTY)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00596986|
Recruitment Status : Unknown
Verified July 2009 by Charite University, Berlin, Germany.
Recruitment status was: Active, not recruiting
First Posted : January 17, 2008
Last Update Posted : August 3, 2009
|Condition or disease||Intervention/treatment||Phase|
|Chronic Depression||Drug: Duloxetine Behavioral: Cognitive Behavioural Analysis System of Psychotherapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||Impact of Therapeutical Strategies on Emotional Processing in Depression: Neurofunctional and Clinical Issues in the Context of Affective Bias|
|Study Start Date :||October 2008|
|Estimated Primary Completion Date :||September 2009|
Active Comparator: AD
Duloxetine 30mg up to 120mg per day.
Active Comparator: PT
Psychotherapy (CBASP) - Cognitive Behavioural Analysis System of Psychotherapy
Behavioral: Cognitive Behavioural Analysis System of Psychotherapy
Cognitive Behavioural Analysis System of Psychotherapy (CBASP): 20 sessions of psychotherapy, beginning with twice weekly, then weekly sessions.
- Neuroimaging Data (fMRI) [ Time Frame: Before and After Therapy ]
- HAMD [ Time Frame: Weekly ]
- Salivary Cortisol [ Time Frame: Before and After Therapy ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00596986
|Berlin, Germany, 14050|
|Study Chair:||Isabella Heuser, Prof. Dr. med. Dipl. Psych.||Dept. of Psychiatry, Campus Benjamin Franklin, Charité Berlin, Germany|
|Principal Investigator:||Michael Colla, Dr. med.||Department of Psychiatry, Campus Benjamin Franklin, Charité Berlin, Germany|